• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

营养保健品和食品补充剂评估。

Assessment of nutraceuticals and food supplements.

出版信息

Panminerva Med. 2011 Sep;53(3 Suppl 1):I-II.

PMID:22108488
Abstract

It is now possible to define food supplements on the basis of their preclinical or clinical action. Nutraceuticals and food supplements when used as drugs to prevent or treat clinical conditions could be defined as Pre-drugs (Preventive drugs or pre-clinical drugs). Nutraceuticals, when used with the aim to limit the continuous use of patented drugs, theoretically more dangerous, more expensive and causing more interactions could be defined as Substitutive-low-risk (SLR)-drugs.For these natural products the real ground of evaluation is the patient, or the subject at risk, possibly, the borderline patient. In this supplement, our research group and network present some of our recent research and innovations particularly focusing on 'natural compounds' of very high preventive and clinical potentials. The combination of so many experts from different medical fields makes this interaction very interesting and promising. More studies and more applications for nutraceuticals and food supplements are coming.

摘要

现在可以根据食品补充剂的临床前或临床作用对其进行定义。如果将营养保健品和食品补充剂用作预防或治疗临床病症的药物,那么它们可以被定义为前药(预防药物或临床前药物)。如果营养保健品旨在限制专利药物的持续使用,而这些药物理论上更危险、更昂贵且更容易产生相互作用,那么它们可以被定义为替代低风险(SLR)药物。对于这些天然产品,真正的评估基础是患者或有风险的个体,可能是处于边缘状态的患者。在本次增刊中,我们的研究小组和网络展示了我们最近的一些研究和创新成果,特别关注具有非常高的预防和临床潜力的“天然化合物”。来自不同医学领域的众多专家的合作使这种互动非常有趣和有前途。更多关于营养保健品和食品补充剂的研究和应用正在涌现。

相似文献

1
Assessment of nutraceuticals and food supplements.营养保健品和食品补充剂评估。
Panminerva Med. 2011 Sep;53(3 Suppl 1):I-II.
2
The rational use of dietary supplements and nutraceuticals in clinical medicine.膳食补充剂和营养保健品在临床医学中的合理应用。
Mt Sinai J Med. 2005 May;72(3):161-5.
3
The quality of commercially available nutraceutical supplements and food sources.市售的营养保健品和食物来源的质量。
J Pharm Pharmacol. 2011 Jan;63(1):3-10. doi: 10.1111/j.2042-7158.2010.01159.x. Epub 2010 Oct 11.
4
Legislation relating to nutraceuticals in the European Union with a particular focus on botanical-sourced products.欧盟与营养保健品相关的法规,尤其侧重于植物源产品。
Toxicology. 2006 Apr 3;221(1):75-87. doi: 10.1016/j.tox.2006.01.014. Epub 2006 Feb 17.
5
The interference of botanicals and nutraceuticals with the effects of antithrombotic agents: how should the available evidence be weighed?植物药和营养保健品对抗血栓药物疗效的干扰:应如何权衡现有证据?
Thromb Res. 2005;117(1-2):19-24; discussion 39-42. doi: 10.1016/j.thromres.2005.09.001. Epub 2005 Oct 18.
6
European regulations on nutraceuticals, dietary supplements and functional foods: a framework based on safety.欧洲关于营养保健品、膳食补充剂和功能性食品的法规:基于安全性的框架
Toxicology. 2006 Apr 3;221(1):59-74. doi: 10.1016/j.tox.2005.12.022. Epub 2006 Feb 15.
7
Dietary supplements and related products: a brief summary.膳食补充剂及相关产品:简要概述。
Life Sci. 2006 Mar 27;78(18):2026-32. doi: 10.1016/j.lfs.2005.12.017. Epub 2006 Feb 23.
8
Nutraceuticals: miracle or meme?营养保健品:奇迹还是炒作?
Clin Pharmacol Ther. 2007 Oct;82(4):352-6. doi: 10.1038/sj.clpt.6100354.
9
[Development of antituberculous drugs: current status and future prospects].[抗结核药物的研发:现状与未来前景]
Kekkaku. 2006 Dec;81(12):753-74.
10
The role of cellular micronutrient analysis, nutraceuticals, vitamins, antioxidants and minerals in the prevention and treatment of hypertension and cardiovascular disease.细胞微量营养素分析、营养保健品、维生素、抗氧化剂和矿物质在高血压及心血管疾病预防和治疗中的作用。
Ther Adv Cardiovasc Dis. 2010 Jun;4(3):165-83. doi: 10.1177/1753944710368205. Epub 2010 Apr 16.

引用本文的文献

1
Pycnogenol® Supplementation Prevents Recurrent Urinary Tract Infections/Inflammation and Interstitial Cystitis.补充碧萝芷®可预防复发性尿路感染/炎症和间质性膀胱炎。
Evid Based Complement Alternat Med. 2021 Jun 23;2021:9976299. doi: 10.1155/2021/9976299. eCollection 2021.
2
Management of Varicose Veins and Chronic Venous Insufficiency in a Comparative Registry with Nine Venoactive Products in Comparison with Stockings.在一个包含九种活性静脉产品与弹力袜对比的比较登记研究中对静脉曲张和慢性静脉功能不全的管理。
Int J Angiol. 2017 Sep;26(3):170-178. doi: 10.1055/s-0036-1597756. Epub 2016 Dec 28.
3
A Clinical Comparison of Pycnogenol, Antistax, and Stocking in Chronic Venous Insufficiency.
碧萝芷、脉之灵和弹力袜治疗慢性静脉功能不全的临床比较
Int J Angiol. 2015 Dec;24(4):268-74. doi: 10.1055/s-0035-1556060. Epub 2015 Jul 15.
4
French Oak Wood (Quercus robur) Extract (Robuvit) in Primary Lymphedema: A Supplement, Pilot, Registry Evaluation.法国橡木(夏栎)提取物(罗布力特)用于原发性淋巴水肿:一项补充性、试点性、注册评估研究
Int J Angiol. 2015 Mar;24(1):47-54. doi: 10.1055/s-0034-1395982.